Pivot Point: When Burnout Becomes Breakthrough

In this episode of "PEMBA On Demand," Dr. Joseph Nounou, a 2020 PEMBA graduate, shares his transition from anesthesia to founding Auros Pharma, a biotech startup tackling the opioid crisis with a novel medication. He discusses his motivations for pursuing an MBA, the challenges of launching a pharmaceutical company during COVID-19, and the personal and financial sacrifices involved. Dr. Nounou emphasizes the importance of physician leadership in drug development and his commitment to affordable, life-saving treatments, highlighting how business education empowered him to drive innovation and broader impact in healthcare.

Show Highlights:

Transition from clinical practice in anesthesia to entrepreneurship in biotech.
Founding of Auros Pharma to address the opioid crisis with a novel medication.
Motivations for pursuing an MBA to gain business knowledge.
Challenges faced during the COVID-19 pandemic and their impact on business management.
Personal transformation driven by burnout and a desire for a more fulfilling career.
The process of bootstrapping a pharmaceutical startup and financial realities involved.
Importance of physician involvement in the pharmaceutical industry and drug development.
Regulatory complexities and the FDA approval process for new medications.
The role of physicians in promoting effective and cost-efficient prescribing practices.
Future aspirations for Auros Pharma's medication and the impact of mentorship from the PEMBA program.

Show Notes

Show Highlights:

Links and Resources:

Other Episodes

Episode 6

CMMI Direct Contracting: Foundational Concepts and Considerations 06

Episode 1

Nader Mergers and Acquisitions 01

Episode

Navigating a Crisis: The Pandemic's Influence on Medical Education with a Veteran Physician Executive